NovoCure GmbH, a subsidiary of NovoCure Ltd., is a company headquartered in Munich, Germany, that develops proprietary therapy. Wilhelmus C. M. Groenhuysen and Asaf Danziger are the current co-CEOs of the firm.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Celltech Co., Ltd. is engaged in producing and developing healthcare and biopharmaceutical products. Its main products include anticancer cell therapy which is named by NKM(Natural Killer Mix cell) Injection, GMP(Good Manufacturing Practice) system and medical devices. The company was founded on August 20, 1986 and is headquartered in Sungnam, South Korea.

Shanghai Nanotechnology and Application National Engineering Research Center Co., Ltd., established on 2004-08-20, Business scope includes research and development of nanotechnology and related technologies,Production and sales of nano-related products,Technology development in the nanosphere,technology transfer,technical consulting,Technical Services,Investment in projects and products,account Serive. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

IMGT Corp. Ltd. develops innovative tumor treatment via image guided therapy. It specializes in ultrasound mediated drug (or) gene delivery method. The company was founded on April 5, 2010 and is headquartered in Seongnam, South Korea.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway.

Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.

PANAX ETEC Co., Ltd. engages in the manufacture and sale of electronic materials such as electrolyte made from coal chemical compounds and other basic chemicals. The company was founded on August 20, 2009 and is headquartered in Busan, South Korea.

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins. Their companyTheraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.

Zuocheng (Shanghai) New Material Technology Development Co., Ltd., established on 2003-02-13, Business scope includes general items:engage in new materials,Ecotechnology,Intelligent Technology,Internet technology,Technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services;metallic material,steel,Insulation Materials,Special equipment for environmental protection,Decoration material,valve piping,Computers and Accessories,Minerals(Except for special items),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Office Supplies,hotel equipment,Sales of edible agricultural products;Mechanical equipment and accessories(Except special equipment)wholesale,retail;business inquiries;Domestic Freight Forwarding;International Freight Forwarding;computer graphic design;Etiquette service;Corporate PR planning;Import and export;Technology Import and Export;Industrial Investment(Excluding equity investment and equity investment management).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Ansheng Pharmaceutical Co., Ltd., established on 2015-09-14, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).Information Consulting(No restricted items);Economic Information Consulting(No restricted items);Trade Consulting;Business Management Consulting(No restricted items);Business Consulting;Pharmaceutical Marketing Planning;Market Research Analysis Consulting;Medical Technology Services;Medical Technology Consulting;Promotion of medical technology;Medical Information Consultation.,The licensing program is:Wholesale and retail of medicines;Wholesale and retail of medical devices;Healthy food,Pre-packaged food(No reheated pre-packaged food),food(non-physical means)promotion of;General cargo,Dedicated transport of goods(Refrigerated).